Transcription factor dependencies identify BAF-dependent cancers

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The BAF (BRG1/BRM-associated factor) complex is a crucial chromatin remodeler involved in various cellular processes.
• Dysregulation of chromatin remodeling complexes, including the BAF complex, is implicated in tumorigenesis.
• Specific cancer types exhibit unique dependencies on cellular machinery for their growth and survival.

Purpose of the Study:

• To identify specific cancer types that are critically dependent on the BAF chromatin remodeling complex.
• To explore the role of transcription factors IRF4 and POU2F3 in BAF complex-dependent cancers.
• To highlight potential therapeutic strategies targeting the BAF complex in identified cancers.

Main Methods:

• Analysis of cancer cell lines and patient-derived samples.
• Genetic and pharmacological manipulation of BAF complex components.
• Assessment of cellular phenotypes, including proliferation and survival.
• Identification of key transcription factors driving BAF dependency.

Main Results:

• Multiple myeloma, particularly IRF4-driven cases, demonstrates a strong dependence on the BAF complex.
• POU2F3-subtype small cell lung cancer is also identified as BAF complex-dependent.
• These findings reveal specific vulnerabilities in these cancer types related to BAF complex function.

Conclusions:

• The BAF chromatin remodeling complex is a critical dependency in specific hematological and lung cancers.
• Targeting the BAF complex with inhibitors or degraders presents a promising therapeutic avenue for IRF4-driven multiple myeloma and POU2F3-subtype small cell lung cancer.
• Further research into BAF complex-targeted therapies is warranted for these malignancies.